CD8A and neoplasm: isolated a consortium of 11 bacterial strains from fecal samples of healthy human donors that could strongly induce interferon-γ(IFN-γ)-producing CD8+ T-cells in the gut and enhance the therapeutic efficacy of ICIs in genotypic tumor models (31).